Keshri P, Singh S
Arch Toxicol. 2024; 98(10):3169-3190.
PMID: 39136731
DOI: 10.1007/s00204-024-03829-9.
M Al-Subaie A, Kamaraj B, Ahmad F, Alsamman K
F1000Res. 2024; 12:345.
PMID: 39119195
PMC: 11307142.
DOI: 10.12688/f1000research.131013.2.
Xiang S, Lu X
Acta Pharm Sin B. 2024; 14(2):517-532.
PMID: 38322338
PMC: 10840435.
DOI: 10.1016/j.apsb.2023.11.010.
Xu X, Song L, Li Y, Guo J, Huang S, Du S
J Transl Med. 2023; 21(1):733.
PMID: 37848983
PMC: 10583391.
DOI: 10.1186/s12967-023-04609-2.
Zhu T, Xie J, He H, Li H, Tang X, Wang S
Proc Natl Acad Sci U S A. 2023; 120(42):e2219589120.
PMID: 37812694
PMC: 10589674.
DOI: 10.1073/pnas.2219589120.
Targeted therapies in non-small cell lung cancer: present and future.
McLaughlin J, Berkman J, Nana-Sinkam P
Fac Rev. 2023; 12:22.
PMID: 37675274
PMC: 10477963.
DOI: 10.12703/r/12-22.
Neuroprotective and Disease-Modifying Effects of the Triazinetrione ACD856, a Positive Allosteric Modulator of Trk-Receptors for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
Parrado Fernandez C, Juric S, Backlund M, Dahlstrom M, Madjid N, Lidell V
Int J Mol Sci. 2023; 24(13).
PMID: 37446337
PMC: 10342804.
DOI: 10.3390/ijms241311159.
Design, synthesis and biological evaluation of pyrazolo[3,4-]pyridine derivatives as TRK inhibitors.
Liu N, Wang X, Fu Q, Qin Q, Wu T, Lv R
RSC Med Chem. 2023; 14(1):85-102.
PMID: 36760745
PMC: 9890667.
DOI: 10.1039/d2md00334a.
Molecular Mechanisms in the Vascular and Nervous Systems following Traumatic Spinal Cord Injury.
Li S, Dinh H, Matsuyama Y, Sato K, Yamagishi S
Life (Basel). 2023; 13(1).
PMID: 36675958
PMC: 9866624.
DOI: 10.3390/life13010009.
Non-small-cell lung cancer: how to manage - and -rearranged disease.
Marinelli D, Siringo M, Metro G, Ricciuti B, Gelibter A
Drugs Context. 2022; 11.
PMID: 36303600
PMC: 9576009.
DOI: 10.7573/dic.2022-3-1.
Toward in vivo proof of binding of F-labeled inhibitor [F]TRACK to peripheral tropomyosin receptor kinases.
Wuest M, Bailey J, Dufour J, Glubrecht D, Omana V, Johnston T
EJNMMI Res. 2022; 12(1):46.
PMID: 35907096
PMC: 9339071.
DOI: 10.1186/s13550-022-00915-w.
Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease.
Carlyle B, Kitchen R, Mattingly Z, Celia A, Trombetta B, Das S
Front Neurol. 2022; 13:889647.
PMID: 35734478
PMC: 9207419.
DOI: 10.3389/fneur.2022.889647.
NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance.
Liu F, Wei Y, Zhang H, Jiang J, Zhang P, Chu Q
Front Oncol. 2022; 12:864666.
PMID: 35372074
PMC: 8968138.
DOI: 10.3389/fonc.2022.864666.
Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia.
Jedraszek K, Malczewska M, Parysek-Wojcik K, Lejman M
Int J Mol Sci. 2022; 23(6).
PMID: 35328487
PMC: 8950780.
DOI: 10.3390/ijms23063067.
The Roles of Neurotrophins in Traumatic Brain Injury.
Lin P, Kuo L, Luh H
Life (Basel). 2022; 12(1).
PMID: 35054419
PMC: 8780368.
DOI: 10.3390/life12010026.
Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumors.
Zhu L, Hobbs B, Roszik J, Holla V, Hong D
Invest New Drugs. 2021; 40(1):157-162.
PMID: 34341905
DOI: 10.1007/s10637-021-01157-8.
Y-27632, a ROCK inhibitor, improved laser-induced shock wave (LISW)-induced cochlear synaptopathy in mice.
Koizumi Y, Mizutari K, Kawauchi S, Sato S, Shiotani A, Kakehata S
Mol Brain. 2021; 14(1):105.
PMID: 34217338
PMC: 8254252.
DOI: 10.1186/s13041-021-00819-1.
Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for fusion cancers.
Jiang T, Wang G, Liu Y, Feng L, Wang M, Liu J
Acta Pharm Sin B. 2021; 11(2):355-372.
PMID: 33643817
PMC: 7893124.
DOI: 10.1016/j.apsb.2020.05.004.
Plasma BDNF and TrkB mRNA in PBMCs Are Correlated With Anti-depressive Effects of 12-Weeks Supervised Exercise During Protracted Methamphetamine Abstinence.
Yang J, Tan J, Zheng L, Lu C, Hou W, Liu Y
Front Mol Neurosci. 2020; 13:20.
PMID: 32210759
PMC: 7069447.
DOI: 10.3389/fnmol.2020.00020.
Regeneration of skin appendages and nerves: current status and further challenges.
Weng T, Wu P, Zhang W, Zheng Y, Li Q, Jin R
J Transl Med. 2020; 18(1):53.
PMID: 32014004
PMC: 6996190.
DOI: 10.1186/s12967-020-02248-5.